MiniMedTM 780G System ^

Anticipates.
Adjusts.
Corrects.1,2

Automated for an easier* way to stabilise glucose levels1,2,3

Learn more

 

^ Components sold separately
*Compared to the MiniMedTM 670G system. Refers to SmartGuardTM feature. Some user interaction required. Indiviual results may very.
Always Read the Instruction for Use. Medtronic's (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes. Guardian™ Sensor 3 may also be used as part of the MiniMed® 780G system^ for people living with Type 1 diabetes age 7 and up.

MM780G Devices

GuardianTM Connect System

Connect
the dots

With glucose levels, trends and alerts on your mobile device

Learn more

MiniMedTM Mobile Apps

Peace of mind
on the go

Stay in the loop with mobile connectivity for you and your loved ones

Learn more

CareLinkTM System

Taking care of
your data

See the same reports as your doctor - and collaborate on your care

Learn more

1. Carlson, A.L. et al. 97-P- Safety and glycaemic outcomes of the MiniMed™AHCL System in subjects with T1D. 80th ADA International Conference, June2020, Chicago+E24

2. Collyns, O. et al. 199-OR- Improved glycaemic Outcomes with MiniMed™AHCL Delivery. 80th ADA International Conference, June 2020, Chicago

3. Bergenstal, R. M. et al. Safety of a Hybrid-Closed Loop Insulin Delivery Systemin Patients with Type 1 Diabetes Jama. 2016; 316 (13): 1407 - 1408